Industry Educational and Promotional Session - A spotlight on adult patient cases with t-AML and AML-MRC – multidisciplinary team decision-making explored. A promotional symposium organised and sponsored by Jazz Pharmaceuticals
Tracks
Track 2
Monday, April 29, 2024 |
1:25 PM - 2:10 PM |
Hall 1C |
Details
Join our panel discussion on selecting suitable treatments for different therapy-related acute myeloid leukaemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) cohorts.
A Jazz Pharmaceuticals promotional symposium – intended for UK Healthcare Professionals only.
Speaker
Dr. Victoria Campbell
Consultant
Western General Hospital
-
Prof James Cavenagh
Consultant Haematologist & Honorary Professor
St Bartholomew’s hospital
-
Dr. Rachel Protheroe
Consultant Haematologist
University Hospitals Bristol & Weston NHS Foundation Trust
-
Miss. Beatriz Santos
Senior Staff Nurse/senior Clinical Practice Facilitator
University College London Hospital
-